Greenwoods Asset Management Hong Kong Ltd. Hutchmed (China) LTD Transaction History

Greenwoods Asset Management Hong Kong Ltd.

$3.79 Billion
Q2 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 13, 2021	SELL	$23.7 - $39.27 $2.37 Million - $3.93 Million	-100,169 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$27.01 - $36.8 $2.71 Million - $3.69 Million	100,169 New	100,169 $2.83 Million

Others Institutions Holding HCM

# of Institutions

Shares Held

8.25M

Call Options Held

3.8K

Put Options Held

2.4K

Schroder Investment Management Group London, X0

3.02M
Shares

$54.4 Million
0.06% of portfolio
Allianz Asset Management Gmb H Munich, 2M

1.5M
Shares

$27 Million
0.04% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.15M
Shares

$20.7 Million
0.33% of portfolio
Acadian Asset Management LLC Boston, MA

389K
Shares

$7 Million
0.02% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

358K
Shares

$6.44 Million
0.0% of portfolio

View Full List

About HUTCHMED (China) Ltd

Ticker HCM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 172,955,008
Market Cap $3.11B
Description
HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and rena...

More about HCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwoods Asset Management Hong Kong Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Greenwoods Asset Management Hong Kong Ltd. with notifications on news.

Account